KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $10.5 million.

  • Vir Biotechnology's Non Operating Income fell 4106.06% to $10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.2 million, marking a year-over-year decrease of 2959.74%. This contributed to the annual value of $64.1 million for FY2024, which is 1416.66% up from last year.
  • Per Vir Biotechnology's latest filing, its Non Operating Income stood at $10.5 million for Q3 2025, which was down 4106.06% from $7.6 million recorded in Q2 2025.
  • Vir Biotechnology's Non Operating Income's 5-year high stood at $164.1 million during Q3 2021, with a 5-year trough of -$91.9 million in Q1 2022.
  • In the last 5 years, Vir Biotechnology's Non Operating Income had a median value of $12.5 million in 2024 and averaged $10.7 million.
  • Within the past 5 years, the most significant YoY rise in Vir Biotechnology's Non Operating Income was 532097.09% (2021), while the steepest drop was 116126.38% (2021).
  • Vir Biotechnology's Non Operating Income (Quarter) stood at -$25.9 million in 2021, then surged by 95.61% to -$1.1 million in 2022, then surged by 1707.31% to $18.3 million in 2023, then tumbled by 31.68% to $12.5 million in 2024, then fell by 16.07% to $10.5 million in 2025.
  • Its Non Operating Income was $10.5 million in Q3 2025, compared to $7.6 million in Q2 2025 and $18.6 million in Q1 2025.